Primary Site >> Liver Cancer

Gene >> RGN

  • 2003
  • 2004
  • 2007
  • 2009
  • 2011
  • 2013
  • 2014
  • 2016
  • 2018
Ref: Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells.
PMID: 14523995
Ref: Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells.
PMID: 15358188
Ref: Identification of biomarkers associated with the development of hepatocellular carcinoma in CuZn superoxide dismutase deficient mice.
PMID: 17514684
Ref: Over-expression of Senescence Marker Protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells.
PMID: 19801822
Ref: Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
PMID: 21047503
Ref: SP1 suppresses phorbol 12-myristate 13-acetate induced up-regulation of human regucalcin expression in liver cancer cells.
PMID: 21526343
Ref: Gel-based proteomics of liver cancer progression in rat.
PMID: 21683810
Ref: Suppressive role of regucalcin in liver cell proliferation: involvement in carcinogenesis.
PMID: 23692083
Ref: Soluble expression of recombinant human SMP30 for detecting serum SMP30 antibody levels in hepatocellular carcinoma patients.
PMID: 23725145
Ref: Inhibition of SMP30 gene expression influences the biological characteristics of human Hep G2 cells.
PMID: 24606440
Ref: Diverse Basis of beta-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
PMID: 27100093
Ref: Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma.
PMID: 27991558
Ref: Diagnostic Value of Serum SMP30 and Anti-SMP30 Antibody in Hepatocellular Carcinoma.
PMID: 29562243
Ref: High Frequency of beta-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.
PMID: 30201494